{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:45:41Z","timestamp":1778291141975,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nature Science Foundation of Hubei Province","award":["2018CFB353"],"award-info":[{"award-number":["2018CFB353"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12891-018-2358-2","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T10:12:14Z","timestamp":1543831934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and safety of oral compared with intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: a meta-analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaozhen","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naili","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-8019","authenticated-orcid":false,"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"issue":"1","key":"2358_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/1874325001105010080","volume":"5","author":"JA Singh","year":"2011","unstructured":"Singh JA. Epidemiology of knee and hip arthroplasty: a systematic review. Open Orthop J. 2011;5(1):80\u20135.","journal-title":"Open Orthop J"},{"issue":"2","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1213\/ANE.0b013e31825b6824","volume":"115","author":"M Kirksey","year":"2012","unstructured":"Kirksey M, Chiu YL, Ma Y, et al. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008. Anesth Analg. 2012;115(2):321\u20137.","journal-title":"Anesth Analg"},{"issue":"21","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.2106\/JBJS.N.00128","volume":"96","author":"KE Ponnusamy","year":"2014","unstructured":"Ponnusamy KE, Kim TJ, Khanuja HS. Perioperative Blood Transfusions in Orthopaedic Surgery. J Bone Joint Surg Am Vol. 2014;96(21):1836.","journal-title":"J Bone Joint Surg Am Vol"},{"issue":"9034","key":"2358_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0140-6736(96)04330-9","volume":"348","author":"JL Carson","year":"1996","unstructured":"Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348(9034):1055\u201360.","journal-title":"Lancet"},{"issue":"06","key":"2358_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-2007-996127","volume":"23","author":"S Okamoto","year":"1997","unstructured":"Okamoto S, Hijikataokunomiya A, Wanaka K, et al. Enzyme-controlling medicines: introduction. Semin Thromb Hemost. 1997;23(06):493\u2013501.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2358_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.otsr.2012.05.002","volume":"98","author":"E Irisson","year":"2012","unstructured":"Irisson E, H\u00e9mon Y, Pauly V, et al. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res Otsr. 2012;98(5):477\u201383.","journal-title":"Orthop Traumatol Surg Res Otsr"},{"issue":"7","key":"2358_CR7","first-page":"E439","volume":"45","author":"JF Diblasi","year":"2016","unstructured":"Diblasi JF, Smith RP, Garavaglia J, et al. Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in Total hip and knee arthroplasty. Am J Orthop. 2016;45(7):E439\u201343.","journal-title":"Am J Orthop"},{"issue":"12","key":"2358_CR8","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.arth.2014.03.032","volume":"29","author":"C Yue","year":"2014","unstructured":"Yue C, Kang P, Yang P, et al. Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty. 2014;29(12):2452\u20136.","journal-title":"J Arthroplasty"},{"issue":"1","key":"2358_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.knee.2015.09.004","volume":"23","author":"JY Chen","year":"2016","unstructured":"Chen JY, Chin PL, Moo IH, et al. Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: a double-blinded randomised controlled noninferiority trial. Knee. 2016;23(1):152\u20136.","journal-title":"Knee"},{"issue":"2","key":"2358_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3928\/01477447-20160301-05","volume":"39","author":"ZX Lin","year":"2016","unstructured":"Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics. 2016;39(2):119\u201330.","journal-title":"Orthopedics"},{"issue":"9","key":"2358_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.arth.2016.02.081","volume":"31","author":"YA Fillingham","year":"2016","unstructured":"Fillingham YA, Kayupov E, Plummer DR, et al. The James a. Rand young Investigator's award: a randomized controlled trial of Oral and intravenous tranexamic acid in Total knee arthroplasty: the same efficacy at lower cost? J Arthroplasty. 2016;31(9):26\u201330.","journal-title":"J Arthroplasty"},{"issue":"1","key":"2358_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.arth.2016.08.026","volume":"32","author":"JL Kim","year":"2017","unstructured":"Kim JL, Park JH, Han SB, et al. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following Total hip and knee arthroplasty: a meta-analysis. J Arthroplasty. 2017;32(1):320.","journal-title":"J Arthroplasty"},{"issue":"41","key":"2358_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004656","volume":"95","author":"Y Chen","year":"2016","unstructured":"Chen Y, Chen Z, Cui S, et al. Topical versus systemic tranexamic acid after total knee and hip arthroplasty:a meta-analysis of randomized controlled trials. Medicine. 2016;95(41):e4656.","journal-title":"Medicine"},{"key":"2358_CR14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"2358_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.","journal-title":"BMJ"},{"issue":"6","key":"2358_CR16","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1213\/01.ANE.0000136770.75805.19","volume":"99","author":"E Zohar","year":"2004","unstructured":"Zohar E, Ellis M, Ifrach N, et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg. 2004;99(6):1679.","journal-title":"Anesth Analg"},{"issue":"11","key":"2358_CR17","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1302\/0301-620X.95B11.31055","volume":"95-B","author":"A Irwin","year":"2013","unstructured":"Irwin A, Khan SK, Jameson SS, et al. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J. 2013;95-B(11):1556\u201361.","journal-title":"Bone Joint J"},{"issue":"5","key":"2358_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2106\/JBJS.16.00188","volume":"99","author":"E Kayupov","year":"2017","unstructured":"Kayupov E, Fillingham YA, Okroj K, et al. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following Total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am Vol. 2017;99(5):373\u20138.","journal-title":"J Bone Joint Surg Am Vol"},{"issue":"9","key":"2358_CR19","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.arth.2017.03.059","volume":"32","author":"X Yuan","year":"2017","unstructured":"Yuan X, Li B, Wang Q, et al. Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study. J Arthroplasty. 2017;32(9):2738\u201343.","journal-title":"J Arthroplasty"},{"key":"2358_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.thromres.2018.02.007","volume":"164","author":"G Cao","year":"2018","unstructured":"Cao G, Huang Z, Xie J, et al. The effect of oral versus intravenous tranexamic acid in reducing blood loss after primary total hip arthroplasty: a randomized clinical trial. Thromb Res. 2018;164:48.","journal-title":"Thromb Res"},{"issue":"3","key":"2358_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1060028017735859","volume":"52","author":"MA Gortemoller","year":"2018","unstructured":"Gortemoller MA, Allen B, Forsyth R, et al. Comparison of Oral and intravenous tranexamic acid for prevention of perioperative blood loss in Total knee and Total hip arthroplasty. Ann Pharmacother. 2018;52(3):246\u201350.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2358_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.arth.2017.09.062","volume":"33","author":"ZY Luo","year":"2017","unstructured":"Luo ZY, Wang HY, Wang D, et al. Oral vs Intravenous vs Topical Tranexamic Acid in Primary Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Study. J Arthroplasty. 2017;33(3):786\u201393.","journal-title":"J Arthroplasty"},{"issue":"1","key":"2358_CR23","doi-asserted-by":"publisher","first-page":"13579","DOI":"10.1038\/s41598-018-31791-x","volume":"8","author":"D Wang","year":"2018","unstructured":"Wang D, Wang HY, Cao C, et al. Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration. Sci Rep. 2018;8(1):13579.","journal-title":"Sci Rep"},{"issue":"10","key":"2358_CR24","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.arth.2012.04.024","volume":"27","author":"N Imai","year":"2012","unstructured":"Imai N, Dohmae Y, Suda K, et al. Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty. 2012;27(10):1838\u201343.","journal-title":"J Arthroplasty"},{"issue":"2","key":"2358_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00590-010-0671-z","volume":"21","author":"R Malhotra","year":"2011","unstructured":"Malhotra R, Kumar V, Garg B. The use of tranexamic acid to reduce blood loss in primary cementless total hip arthroplasty. Eur J Orthop Surg Traumatol. 2011;21(2):101\u20134.","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"21","key":"2358_CR26","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2106\/JBJS.L.00907","volume":"95","author":"S Alshryda","year":"2013","unstructured":"Alshryda S, Mason J, Vaghela M, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am Vol. 2013;95(21):1961\u20138.","journal-title":"J Bone Joint Surg Am Vol"},{"issue":"11","key":"2358_CR27","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1016\/j.arth.2017.06.024","volume":"32","author":"J Wang","year":"2017","unstructured":"Wang J, Wang Q, Zhang X, et al. Intra-articular Application is More Effective Than Intravenous Application of Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. J Arthroplasty. 2017;32(11):3385\u20139.","journal-title":"J Arthroplasty"},{"issue":"7","key":"2358_CR28","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.arth.2016.10.003","volume":"32","author":"Q Sun","year":"2016","unstructured":"Sun Q, Yu X, Wu J, et al. Efficacy of a Single Dose and an Additional Dose of Tranexamic Acid in Reduction of Blood Loss in Total Knee Arthroplasty. J Arthroplasty. 2016;32(7):2108\u201312.","journal-title":"J Arthroplasty"},{"issue":"1","key":"2358_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.arth.2016.06.021","volume":"32","author":"Q Sun","year":"2016","unstructured":"Sun Q, Yu X, Nie X, et al. The efficacy comparison of tranexamic acid for reducing blood loss in Total knee arthroplasty at different dosage time. J Arthroplasty. 2016;32(1):33\u20136.","journal-title":"J Arthroplasty"},{"issue":"7","key":"2358_CR30","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.arth.2010.11.013","volume":"26","author":"X Liu","year":"2011","unstructured":"Liu X, Zhang X, Chen Y, et al. Hidden blood loss after total hip arthroplasty. J Arthroplasty. 2011;26(7):1100\u20131105.e1.","journal-title":"J Arthroplasty"},{"issue":"12","key":"2358_CR31","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ijom.2010.09.003","volume":"39","author":"J Ervens","year":"2010","unstructured":"Ervens J, Marks C, Hechler M, et al. Effect of induced hypotensive anaesthesia vs isovolaemic haemodilution on blood loss and transfusion requirements in orthognathic surgery: a prospective, single-blinded, randomized, controlled clinical study. Int J Oral Maxillofac Surg. 2010;39(12):1168\u201374.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"2358_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/EJA.0000000000000202","volume":"32","author":"S Lasocki","year":"2015","unstructured":"Lasocki S, Krauspe R, Von HC, et al. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol. 2015;32(3):160.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"2358_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00000542-200007000-00035","volume":"93","author":"DR Spahn","year":"2000","unstructured":"Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology. 2000;93(1):242\u201355.","journal-title":"Anesthesiology"},{"key":"2358_CR34","doi-asserted-by":"publisher","first-page":"f7073","DOI":"10.1136\/bmj.f7073","volume":"347","author":"S Padhi","year":"2013","unstructured":"Padhi S, Bullock I, Li L, Stroud M, National Institute for H, Care Excellence Guideline Development G. Intravenous fluid therapy for adults in hospital: summary of NICE guidance. BMJ. 2013;347:f7073.","journal-title":"BMJ"},{"issue":"6","key":"2358_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.annfar.2004.04.012","volume":"23","author":"MM Lucaspolomeni","year":"2004","unstructured":"Lucaspolomeni MM, Delaval Y, Menestret P, et al. A case of anaphylactic shock with tranexamique acid (Exacyl). Annales Francaises Danesthesie Et De Reanimation. 2004;23(6):607.","journal-title":"Annales Francaises Danesthesie Et De Reanimation"},{"issue":"1","key":"2358_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13018-014-0090-7","volume":"9","author":"C Wang","year":"2014","unstructured":"Wang C, Han Z, Zhang T, et al. The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis. J Orthop Surg Res. 2014;9(1):90.","journal-title":"J Orthop Surg Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2358-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-018-2358-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2358-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T19:13:00Z","timestamp":1575313980000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-018-2358-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1186\/s12891-018-2358-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"430"}}